ALD and MLD to be Screened in Newborns in UK Generation Study
source: shutterstock.com

ALD and MLD to be Screened in Newborns in UK Generation Study

Patient Worthy partner Alex TLC has announced that, in a large-scale newborn screening study supported by the UK's NHS and Genomics England, adrenoleukodystrophy (ALD) and metachromatic leukodystrophy (MLD) will be…

Continue Reading ALD and MLD to be Screened in Newborns in UK Generation Study
Gene Therapy for Cerebral Adrenoleukodystrophy Earns FDA Accelerated Approval
source: shutterstock.com

Gene Therapy for Cerebral Adrenoleukodystrophy Earns FDA Accelerated Approval

According to a press release, the gene therapy company bluebird bio, inc. has recently announced that its gene therapy elivaldogene autotemcel (marketed as SKYSONA) has received Accelerated Approval status from…

Continue Reading Gene Therapy for Cerebral Adrenoleukodystrophy Earns FDA Accelerated Approval